Menu
The Challenges
The proposed challenge aims to explore new diagnostic methods and implement tools that streamline symptom analysis and efficiently lead to the appropriate specialist. The significance of this challenge lies in the often–delayed diagnosis, resulting in poorer prognoses. This delay is partly due to the no specificity of some symptoms and the lack of effective screening methods for all types of cancers.
This involves the development of diagnostic or screening methods that enhance existing techniques, whether based on in vitro diagnostics, biomarker analysis, or other methods. The solution should target healthcare professionals and provide benefits compared to current processes. This may involve being less invasive, reducing pain and the risk of complications, decreasing waiting times and stress for patients, achieving more precise and objective diagnoses, or providing data that facilitates tumor classification and supports therapeutic decision-making.
The proposal is for the development of methods and tools to analyze symptoms, conduct pre-diagnoses, referrals, and recommendations, or have risk factor analyses to identify individuals with a higher likelihood of developing gynaecological cancer. The goal is to expedite the detection of symptoms and referral to the appropriate specialist in cases of suspected gynaecological cancer.
These solutions can be aimed at both the general population and healthcare professionals, with a positive emphasis on the personalization of information provided to each user and the humanization of technologies based on natural language processing (NLP) or similar approaches.
This challenge aims to offer patients and caregivers access to information and resources throughout the entire healthcare process, tailoring support to the stage of the process and the specific needs of each patient. The initiative arises from the common doubts that patients experience about the processes they undergo and the feeling of a lack of support in areas beyond clinical treatment, such as nutrition, physical activity, sexuality, fertility, and emotional support.
The objective is to provide comprehensive support throughout the clinical process, aimed at reducing the stress, uncertainty, and doubts of patients, while also lightening the healthcare burden on professionals.
The solution can be oriented towards both patients and professionals, offering support in providing information and resolving doubts about symptoms, next steps, medical guidelines, etc. It can also provide guidance on fertility options specific to each type of cancer or treatment, or facilitate the monitoring of symptoms, medical visits, among other aspects, with the goal of improving disease management.
A solution focused on emotional and psychological support throughout the oncological process and/or after completing treatment is sought. The aim is to provide broader access to psychological support compared to the current resources available in healthcare centers.
The solution should encompass at least the patient, although it can extend to their environment. Personalization and humanization of technology are crucial, adapting recommendations and guidelines according to the needs and characteristics of each patient. It will be positively valued if the solution is or has the vision of being a digital therapy.
Resources and guidelines for health habits for patients in the oncological process are considered, serving as a source of reliable, validated, and aggregated information, addressing areas where public centers have fewer resources, such as sports, nutrition, sexuality, and psychology.
The integration of information from various topics into a single solution, as well as an intuitive interface with audiovisual support ensuring easy tool use, will be appreciated. Personalization of information and having medical validation, thus ensuring its safety in the clinical environment, will also be relevant aspects.
Research centers, universities, startups, entrepreneurs and any individual or entity, national or international, that is the exclusive owner of innovative technologies with the potential to solve the challenges.
Innovative technologies that:
Address one of the challenges and resolve one or more of the proposed use cases.
Can adapt or have the capacity to adapt to the Spanish regulatory framework.
Are protected or in the process of obtaining intellectual property rights.
Have high growth and scalability potential.
Have at least a TRL 6.*
*This implies having a system or subsystem model or prototype demonstration in a relevant environment.
Explore new opportunities with the possibility of creating a collaboration agreement with GSK. Develop and implement your solution with the vision of making it accessible and scalable nationally and internationally.
Receive guidance and support in aspects related to research, development, and strategy within the healthcare sector. Additionally, we will contribute our expertise in regulatory, legal, and operational matters.
Facilitate access to healthcare professionals, patients, companies, and other organizations aligned with the purpose of your solution. Collaborate with relevant stakeholders in the sector to collectively address the challenge.
Submission of applications
February 28 – May 5
Registration form open for the submission of applications.
Pre-screening
April 22 – May 10
Filtering of proposals that meet the selection criteria.
Evaluation
May 13 – 21
Assessment of solutions and selection of finalist.
Finalists’ selection
June 3 – 7
Selection of 5 finalists.
Pitch Day
July 17 – 21
Presentation of finalist to the jury and final evaluation.
Announcement of Winners
July 24 – 28
GSK will Communicate the winning solutions of the initiative.
If you have any questions about the registration process, you can write to:
For more information, please contact your healthcare professional.
NP-ES-AOU-WCNT-240001 (v1) 02/2024